‼️See below terrific opportunity for a postdoc post with a leading group in Oxford, super exciting science! 🔥🔥👇

Marketa Tomkova@marketatomkova.bsky.social · 11mo ago

Please share: we’re recruiting a postdoctoral fellow – applications open until September 15! To lead genomics data analysis of an exciting translational project in sAML cancer, supportive environment, and access to unique in-house technologies. my.corehr.com/pls/uoxrecru...

thanks for highlighting our study @erictopol.bsky.social !

Eric Topol@erictopol.bsky.social · 12mo ago

Platelets sequester and harbor cell-free tumor DNA, which could enhance our ability to make early, microscopic diagnosis of cancer @science.org science.org/doi/10.1126/... science.org/doi/10.1126/...

Thrilled that our paper is in print @science.org!! *Platelets sequester cell free DNA, including free fetal and tumour-derived DNA* Tweetorial from @l-cmurphy.bsky.social below. Check out the news feature science.org/content/arti... and terrific editorial from Dennis Lo #platelets_in_the_limelight

By sucking up DNA, clot-producing platelets could help diagnose cancer

The cells could be a new source of tumor DNA for liquid biopsies

science.org

Lauren Murphy@l-cmurphy.bsky.social · 12mo ago

🚨 New paper alert! 🚨 I’m thrilled and proud to share that our latest work has just been published in @science.org! 🎉 🧽 📖 Read our paper here: doi.org/10.1126/sci... 🎬 Watch a summary: youtu.be/MttCA3GGWEM 🧵 Or keep reading for the key points! 🔑 1/19

MPN community (patients/families) - do join us with MPN voice tomorrow if you are interested to hear updates on all the exciting data presented at the recent European Haematology Congress @mpnvoice.bsky.social @mpnrf.bsky.social www.mpnvoice.org.uk/news/mpn-voi...

MPN Voice ‘virtual’ forum – Post EHA 2025 updates Thu 3 July 2025

mpnvoice.org.uk

Exciting times for mutCALR MPNs - lovely data from the ET cohort presented in late breaking abstract at @EHA_Hematology. Rapid platelet control after just 2 doses with 89% of patients benefitting from a molecular response with INCA033989. @mpnvoice.bsky.social @mpnrf.bsky.social @mpnhv.bsky.social

Exciting job opportunities here for *TWO* computational researchers to contribute to a new collaborative effort between the @imm.ox.ac.uk and @ludwigcancer.bsky.social focussing on progression to high risk blood cancers and secondary leukaemia. Come join our brilliant team!

Marketa Tomkova@marketatomkova.bsky.social · last yr.

We are recruiting! Senior postdoc in computational cancer genomics/epigenomics @ludwigcancer.bsky.social @ox.ac.uk. Lead research into epigenetic drivers of secondary AML with rich omics data + strong clinical/wet-lab collaborations. cutt.cx/YUoB We look forward hearing from you! #epigenetics #jobs

Lovely sunset family picnic serenaded by the geese at the Costa Del Port Meadow. #beautifuloxford

We are recruiting!! Ads now live for a Data Coordinator and 2 Research Assistants/biobankers to join a new @ludwigcancer.bsky.social - @imm.ox.ac.uk joint initiative to prevent progression from early- to advanced blood cancer. Joint posts with Adam Mead+others in Oxford Ludwig. Links below

Thrilled to share new work led by @jieyang437.bsky.social in the lab published today in @Nature. We find that Aspirin prevents metastasis by releasing T cells from immune suppression by platelet TXA2. @Cambridge_Uni @CRUKCamCentre rdcu.be/eci1U

Rare Disease Day is coming up this Friday (28th Feb) 🧪 We spoke with Sarah Gooding, a clinician scientist in @rosschapmanlab.bsky.social's group at the MRC WIMM researching multiple myeloma - a currently incurable type of bone marrow cancer that desperately requires friendlier therapies.

Rare Disease Day 2025: Multiple Myeloma

YouTube video by MRC Weatherall Institute of Molecular Medicine

youtu.be

Check out @imm.ox.ac.uk latest video on innovation - we are fortunate to work in such a dynamic environment, bridging biological discovery and clinical translation @ox.ac.uk @cancerresearchuk.org

MRC Weatherall Institute of Molecular Medicine@imm.ox.ac.uk · last yr.

At the MRC WIMM, we foster a strong culture of innovation. In this video, we spoke with some of our current and former Group Leaders who have developed their discoveries into commercial ventures to translate their research into clinics and benefit patients 🧪 Find out more: bit.ly/4b3zL4O

Check out @abattacks.bsky.social’s new and improved bone marrow organoid model - preprint below. More cell types (lymphoid progenitors and osteo- lineage), myeloma modelling and a cool method to improve scalability!

Abs Khan@abattacks.bsky.social · last yr.

Good morning everyone, I'm pleased to share our latest advance in bone marrow in vitro modelling: www.biorxiv.org/content/10.1...

Hugely well deserved @ckbrierley.bsky.social

MRC Weatherall Institute of Molecular Medicine@imm.ox.ac.uk · 2y ago

Congratulations to all the 2024 RDM Graduate Prize Winners, including @ckbrierley.bsky.social & Patrick Pflughaupt, who both completed their PhDs here at the MRC WIMM 🎉

Super proud of brilliant NIH-OxCAM PhD student ZoeWong for winning the Doug Higgs Best Abstract award at Oxford Centre for Haematology Day @ox.ac.uk @ouhospitals.bsky.social @imm.ox.ac.uk, for her collab project with @alexrampotas.bsky.social. They are racking up prizes betw them…paper coming!

Great paper from @immunothrombosis.bsky.social group - platelets alter their functional properties with time since thrombogenesis. Important implications for transfusion storage time!

Leo Nicolai@immunothrombosis.bsky.social · 2y ago

1/x Online now: Our work on platelet aging and inflammation in @bloodjournal.bsky.social led by superstar PhD student Afra Anjum: ashpublications.org/blood/articl...

Join Us for the MPN Voice Virtual Forum! 🗓 Date: Monday, 6 January 2025 🕒 Time: 4:30 PM – 6:00 PM (GMT)📍 Location: Online (Zoom). Registration is now open! Focusing on the latest updates from the American Society of Hematology (ASH). linktr.ee/Mpnvoice

So proud of DrLaurenMurphy passing PhD @imm.ox.ac.uk with flying colours.Grateful that she was brave enough to join as 2nd lab recruit 6yrs ago, and determined enough to make a huge success of a high-risk-high-reward PhD inspired by a @cancerresearchuk.org sandpit!Thanks examiners ProfsCurry&Gibbins

Excited for this session!

Alba R Meira@albarmeira.bsky.social · 2y ago

There's no better way to start the new year than by hearing the exciting science of organoids! 🤩 Join us for the first 2025 New Investigator Committee webinar on January 8th.

Make sure to get your talk submissions in! Can't wait for this conference and the all-star speakers/science!!

Fusion Conferences@fusionconf.bsky.social · 2y ago

🚨 1 week left to secure your Early Bird registration for #MyeloidMalignancies25 🌍 14-17 May 2025, Chania, Crete 🗣️ Talk submissions accepted until 12 Dec 📰 Programme live; remaining slots reserved for abstracts 🖥️ bit.ly/3ZpUESA

Terrific talk from the brilliant @antoniorromera.bsky.social this morning on how cells tolerate whole genome duplication and implications for cancer evolution. Check it out on the virtual platform if you missed it!

Alex Rampotas@alexrampotas.bsky.social · 2y ago

Very eloquent presentation by Antonio Romera from @bethpsaila.bsky.social lab on megakaryocyte biology and ability to take on DNA damage! Fantastic work #ASH24

Very well deserved @alexrampotas.bsky.social ! We are thrilled to work with you and the CAR-T team

Alex Rampotas@alexrampotas.bsky.social · 2y ago

Very honoured to receive the ASH-BSH abstract achievement award The result of the tremendous work by so many talented people who I had the privilege to work with Zoe Wong, Isaac Gannon, @bethpsaila.bsky.social, Claire Roddie, Martin Pule and many more #ASH24

Very pleased to present the results of a UK wide collaborative study on real world efficacy and safety of Momelotininb - >60% anaemia responses at 6 months -G1-2 peripheral neuropathy (15%) -unexpected thrombocytosis (?hepcidin dysregulation due to AVCR1 inhibition) #ASH24 @bethpsaila.bsky.social

Sunrise and moonset beyond the Coronado Bridge on a beautiful run around San Diego bay this morning

All packed and ready for #ASH24 @ash-hematology.bsky.social! Just trying to decide which essential item to leave behind to get my suitcase to close

Check out our “In a Nutshell” review in Brit J Haem - When, Which and How to Switch - navigating JAK inhibitors for myelofibrosis onlinelibrary.wiley.com/doi/10.1111/...

When, which and how to switch: Navigating JAK inhibitors in myelofibrosis

Navigating choice of JAK inhibitor (JAKi) therapy for patients with myelofibrosis who are JAKi-naïve and for those who have previously been treated with a JAKi.

onlinelibrary.wiley.com

Excited for #ASH24 & thrilled that *3* brilliant folks from the team have oral presentations, travel awards and 2/3 nominated for **best of ASH**!! @imm.ox.ac.uk @ox.ac.uk @cancerresearchuk.org @ludwigcancer.bsky.social